EHC·Encompass Health Corporation
EHC|Analyst Targets
EHC|Insider Trading
EHC|Fundamentals
EHC|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.36 | - | - |
| Q3'25 | $1.19 | $1.23 | +3.2% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.6B | - | - |
| Q3'25 | - | $1.5B | - |
EHC|Monthly Returns
Market Data
EHC Stock Snapshot
- Market cap
- 12.33B
- P/E ratio
- 19.9
- Day range
- $124.70 – $126.72
- News sentiment
- 53/100 · Neutral
- Analyst target
- $148.17 (+16.9%)
- Consensus
- Buy · 20 analysts
Encompass Health Corporation screens well technically, with price sitting near its 52-week high. Earnings and guidance carry more weight than macro data at this capitalisation.
Reverse DCF
What growth is priced into EHC?
At today's price, Encompass Health Corporation needs to grow free cash flow about 12.1% a year for the next 10 years to justify its valuation at a 7.11% cost of capital. Over its actual history it has compounded free cash flow at 1.0% a year, so the market is asking for 11.1 percentage points above its own delivered rate. On that basis EHC looks priced above what its own growth record supports.
- Implied FCF growth
- 12.1%
- Historical FCF CAGR
- 1.0%
- Growth gap
- +11.1 pts
- Verdict
- RICH
- Discount rate (WACC)
- 7.11%
- Beta
- 0.50
Behaviour On Record
What EHC's own history says about today's numbers
- Realized volatility (21d)
- 36.1% 88th pct
- Below its peak
- -0.5%
- vs 200-day average
- +16.3%
- Up days (1y)
- 47%
Encompass Health Corporation is currently running 36.1% annualised volatility over the last 21 sessions. Measured against EHC's own 13 years of daily returns rather than a market-wide average, that is the 88th percentile — elevated for this stock, against a typical reading of 23.7%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
EHC is at its running peak. Across 12 full years on file its median worst-drawdown-in-a-year was -17.5%, with the deepest at -39.5% in 2020 — so highs have historically been given back before they were extended.
Price sits +16.3% from its 200-day moving average. Against every other day in its history, that gap ranks at the 85th percentile — a wider gap than this stock usually carries. Over the past year EHC closed higher on 47% of sessions, and it is currently 1 session into a rising streak.
On October specifically: over 14 years of records, EHC finished the month higher 6 of 14 times, with a median return of -1.0% and an average of -1.1%. Its strongest month historically has been April at +6.7% on average, its weakest December at -2.2%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: EHC has opened more than 2% away from the prior close in 113 of 3,268 sessions (3.5% of the time), with the largest gaps running +10.9% and -17.1%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
All figures computed from 3,269 daily closes between 2013-10-15 and 2026-10-14, split-adjusted, recomputed daily. Percentiles are against EHC's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of EHC's sector?
Encompass Health Corporation sits in the Health Care sector, currently ranked 2nd of 12 GICS sectors by relative-strength rotation score (leading).
- Sector rank
- #2 of 12
- Sector state
- Leading
- Sector rotation score
- 82
Analyst Rating Changes
Are analysts turning bullish or bearish on EHC?
TD Cowen most recently reiterated its rating on Encompass Health Corporation to Buy on Aug 10, 2026 with a price target of $140 (from $125). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- TD Cowen — Buy
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
ETF holders
ETFs holding EHC
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Vanguard Group Inc | ▼ Sell | 10,130,029 | 10.22% | $1.08B | 2026-01-29 |
| BlackRock, Inc. | ▼ Sell | 10,484,385 | 10.57% | $1.06B | 2026-08-07 |
| Wellington Management Group LLP | ▼ Sell | 3,278,739 | 3.31% | $331.41M | 2026-08-14 |
| Citadel Advisors LLC | ▲ Buy | 2,563,104 | 2.58% | $259.08M | 2026-09-02 |
| AllianceBernstein L.P. | ▼ Sell | 2,471,751 | 2.49% | $239.09M | 2026-08-14 |
| Two Sigma Investments, LP | ▲ Buy | 2,267,668 | 2.29% | $229.22M | 2026-08-14 |
| Geode Capital Management, LLC | ▼ Sell | 1,890,743 | 1.91% | $191.16M | 2026-08-12 |
| Goldman Sachs Group Inc | ▼ Sell | 1,550,797 | 1.56% | $156.75M | 2026-08-14 |
| Invesco Ltd. | ▼ Sell | 1,161,108 | 1.17% | $117.36M | 2026-08-14 |
| Norges Bank | ▼ Sell | 1,154,864 | 1.16% | $116.73M | 2026-08-12 |
| William Blair Investment Management, LLC | ▲ Buy | 1,151,085 | 1.16% | $116.35M | 2026-08-12 |
| Morgan Stanley | ▲ Buy | 1,146,873 | 1.16% | $115.93M | 2026-08-13 |
| JPMorgan Chase & Co | ▼ Sell | 1,133,561 | 1.14% | $114.84M | 2026-08-12 |
| Northern Trust Corp | ▲ Buy | 970,684 | 0.98% | $98.12M | 2026-08-13 |
| Capital Research Global Investors | ▲ Buy | 872,540 | 0.88% | $88.20M | 2026-08-12 |
| Millennium Management LLC | ▲ Buy | 805,717 | 0.81% | $81.44M | 2026-08-14 |
| Bank of America Corp | ▼ Sell | 788,090 | 0.79% | $79.66M | 2026-08-14 |
| AQR Capital Management LLC | ▲ Buy | 561,888 | 0.57% | $56.58M | 2026-08-14 |
| D. E. Shaw & Co., Inc. | ▼ Sell | 384,595 | 0.39% | $38.87M | 2026-08-14 |
| Balyasny Asset Management L.P. | ▲ Buy | 296,939 | 0.30% | $30.01M | 2026-08-14 |
| Gotham Asset Management, LLC | ▲ Buy | 260,898 | 0.26% | $26.37M | 2026-08-14 |
| Wells Fargo & Company | ▲ Buy | 197,760 | 0.20% | $19.99M | 2026-08-14 |
| Renaissance Technologies LLC | ▼ Sell | 174,500 | 0.18% | $17.64M | 2026-08-13 |
| FMR LLC (Fidelity) | ▼ Sell | 152,783 | 0.15% | $15.44M | 2026-08-13 |
| Davidson Kempner Capital Management LP | ▲ Buy | 151,267 | 0.15% | $15.29M | 2026-08-14 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Lisa McClain | House | MI09 | ▼ Sell | $1K - $15K | 2025-10-31 | 2025-11-21 |
| Lisa McClain | House | MI09 | ▲ Buy | $1K - $15K | 2025-10-30 | 2025-11-21 |